A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)

NCT04962503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Arterial Ischemic Stroke

Interventions

DRUG: Afamelanotide

Sponsor

Clinuvel Pharmaceuticals Limited